Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Alignment Healthcare, Inc. (NASDAQ: ALHC) earns capitation revenue or manages its medical loss ratio can mean sifting through hundreds of SEC pages. Complex items—CMS risk-adjustment methodology, provider network agreements, or value-based care metrics—often hide in footnotes. Stock Titan’s AI-powered summaries turn those dense disclosures into plain-English insights, so you see the numbers and the nuance without scanning every line.
Whether you need an Alignment Healthcare annual report 10-K simplified or the latest Alignment Healthcare quarterly earnings report 10-Q filing, this page delivers every document the moment it hits EDGAR. Our platform automatically tags material events, making the next Alignment Healthcare 8-K material events explained easy to spot. Real-time alerts highlight Alignment Healthcare insider trading Form 4 transactions and send instant notifications when executives buy or sell shares—ideal for monitoring Alignment Healthcare executive stock transactions Form 4.
Here’s how professionals use these filings:
- Compare member growth trends quarter-over-quarter without wading through actuarial tables.
- Review risk-score disclosures before earnings calls using our AI commentaries.
- Evaluate leadership incentives with the Alignment Healthcare proxy statement executive compensation section pre-highlighted.
Every form—10-K, 10-Q, 8-K, S-1, and more—is indexed, and AI-powered summaries explain filing meanings in simple terms. Need to dive deeper? Open the full document alongside side-by-side analytics that clarify revenue recognition or contract liabilities. From Alignment Healthcare earnings report filing analysis to understanding Alignment Healthcare SEC documents with AI, you’ll find what matters faster, make informed decisions sooner, and never miss another Alignment Healthcare Form 4 insider transactions real-time update.
XCF Global, Inc. (NASDAQ: SAFX) filed an 8-K disclosing two related amendments executed on July 10 2025:
- Amendment No. 1 to a Promissory Note (originally dated May 30 2025) among Focus Impact BH3 NewCo, Inc. (borrower), Helena Global Investment Opportunities I Ltd ("Helena") and Randall Soule. In exchange for a $2,249,771.14 cash payment from Helena, the Company and Soule waived Helena’s obligation to return certain Class A common shares that had been subject to Section 11.2 of the original note.
- Soule Amendment to Share Issuance Agreement (dated May 30 2025) under which Soule will return unspecified Class A shares to the Company for cancellation.
Because Amendment No. 1 alters the payment terms, the disclosure is also reported under Item 2.03 (creation of a direct financial obligation). Forms of both amendments are attached as Exhibits 10.1 and 10.2.
Key take-aways for investors:
- The Company receives $2.25 million in cash, enhancing near-term liquidity.
- The waiver means Helena retains shares that would otherwise have been returned, potentially maintaining share count higher than previously expected.
- Soule’s return of shares partly offsets the dilution, but the precise number of shares affected is not disclosed in the filing.
UiPath, Inc. (PATH) – Form 4 insider transaction
- On 11 July 2025, co-founder, CEO, Chairman and 10% owner Daniel Dines reported the sale of 45,000 Class A shares at a VWAP of $12.7132.
- The disposition was executed under a Rule 10b5-1 pre-arranged trading plan (Footnote 1), indicating the transaction was scheduled in advance.
- Following the sale, Dines’ beneficial ownership stands at 30,351,961 Class A shares (24,918,585 direct; 5,193,376 indirect via Ice Vulcan Holding Ltd.; 240,000 indirect via spouse), representing a minor reduction (~0.15%) of his total reported holdings.
- The price range for the trade was $12.67 – $12.81; detailed breakdown is available upon request (Footnote 2).
- Control of the indirect shares remains with Dines through Ice Vulcan Holding Ltd., as detailed in Footnote 3.
This filing reflects a routine, plan-based sale that has a negligible impact on Dines’ overall stake and does not alter the company’s capital structure.
Alignment Healthcare (ALHC) – Amended Form 4 (Form 4/A)
CEO and Director John E. Kao corrected a prior Form 4 to reflect the accurate number of shares withheld for tax obligations triggered by the vesting of service-based restricted stock units (RSUs). On 08-Mar-2024, 35,801 common shares were automatically withheld at an implied price of $5.39 per share under Transaction Code “F” (tax-withholding, non-discretionary). Following the adjustment, Kao’s direct beneficial ownership stands at 2,310,972 shares.
The filing explicitly states that no investment decision was made; the shares were removed solely to satisfy federal tax liabilities. The amendment rectifies an “administrative error” in the original Form 4 filed on 12-Mar-2024.
- Nature of transaction: Non-open-market, tax-withholding event.
- Impact on insider’s stake: Less than 2% reduction in Kao’s holdings; he retains a substantial ownership position.
- Market significance: Typically viewed as neutral because it is mandatory and does not signal sentiment about ALHC’s prospects.
Sinclair, Inc. (SBGI) – Form 3 filing: Newly appointed Executive Vice President & Chief Financial Officer Narinder Sahai has reported initial beneficial ownership of 118,244 Class A common shares. The shares are issued as restricted stock that will vest 100% on July 7, 2028. No derivative securities were disclosed. The filing date is July 10, 2025 and the reportable event occurred on July 7, 2025. The ownership is held directly, indicating personal equity alignment with shareholders. No changes to outstanding share count, earnings, or major transactions are included in this brief compliance filing.
FAQ
What is the current stock price of Alignment Healthcare (ALHC)?
What is the market cap of Alignment Healthcare (ALHC)?
What is the core focus of Alignment Healthcare?
How does Alignment Healthcare leverage technology in its operations?
What services does Alignment Healthcare provide to its members?
How does the company differentiate itself in the competitive healthcare market?
Who are the primary beneficiaries of Alignment Healthcare's services?
Does Alignment Healthcare partner with local providers?
What industry terms best describe Alignment Healthcare's approach?
How does Alignment Healthcare ensure cost management while delivering quality care?
